Dr. Gustavo Dziewczapolski is the Scientific Director of Cure CMD in Torrance, CA, USA, and serves on the Muscular Dystrophy Coordinating Committee (MDCC) at the NIH. With a PhD in Neuropharmacology, he specializes in congenital muscular dystrophies (CMD) and translational research. In his role, Dr. Dziewczapolski acts as a vital link between the patient community and scientific researchers, helping to accelerate the development of treatments for CMD subtypes, including LAMA2-related disorders.